Wednesday, October 7, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· November 25, 2025

Stock market today: Dow, S&P 500, Nasdaq rally for 3rd day as Fed rate cut hopes grow, Apple and Alphabet notch records

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, Nasdaq rally for 3rd day as Fed rate cut hopes grow, Apple and Alphabet notch records US stocks ended sharply higher Tuesday, building on a broad rebound fueled by growing optimism that the Federal Reserve will deliver a rate cut next month, while tech heavyweights Alphabet (GOOG, GOOG…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Nvidia's GPUs are clearly not going anywhere

    80% confidence

  • Right now the overarching theme is of compute scarcity, and if anything this feels like an effort to secure more

    80% confidence

  • Custom AI Companion is scaling with several Fortune 200 wins and broad interest

    80% confidence

  • AI isn't just bolstering our core, it's opening new revenue streams and deeper customer value through customization and automation

    80% confidence

  • We believe that Fed rate cuts, robust corporate earnings, and the AI growth story will sustain the equity rally into 2026

    80% confidence

  • The success of Google's TPUs is not new

    80% confidence

  • Federal Reserve should ease interest rates

    80% confidence

Data points we hold from this source

Board of Governors of the Federal Reserve System · policy rate cut probability80 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com
Stock market today: Dow, S&P 500, Nasdaq rally for 3rd day as Fed rate cut hopes grow, Apple and Alphabet notch records — Source | Via News | ViaNews Market